MY190309A - Beta-casein a2 and reducing or preventing symptoms of lactose intolerance - Google Patents
Beta-casein a2 and reducing or preventing symptoms of lactose intoleranceInfo
- Publication number
- MY190309A MY190309A MYPI2019006591A MYPI2019006591A MY190309A MY 190309 A MY190309 A MY 190309A MY PI2019006591 A MYPI2019006591 A MY PI2019006591A MY PI2019006591 A MYPI2019006591 A MY PI2019006591A MY 190309 A MY190309 A MY 190309A
- Authority
- MY
- Malaysia
- Prior art keywords
- casein
- beta
- reducing
- lactose intolerance
- preventing symptoms
- Prior art date
Links
- 102000011632 Caseins Human genes 0.000 title abstract 4
- 108010076119 Caseins Proteins 0.000 title abstract 4
- 235000021247 β-casein Nutrition 0.000 title abstract 4
- 201000010538 Lactose Intolerance Diseases 0.000 title abstract 2
- 208000024891 symptom Diseases 0.000 title abstract 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Gastroenterology & Hepatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Confectionery (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361845480P | 2013-07-12 | 2013-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY190309A true MY190309A (en) | 2022-04-13 |
Family
ID=52280344
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2019006591A MY190309A (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
| MYPI2016700051A MY172939A (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2016700051A MY172939A (en) | 2013-07-12 | 2014-07-10 | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US20160136238A1 (https=) |
| EP (2) | EP3542805A1 (https=) |
| JP (2) | JP6436592B2 (https=) |
| KR (2) | KR102367941B1 (https=) |
| CN (3) | CN110800803A (https=) |
| AU (2) | AU2014287862B2 (https=) |
| BR (1) | BR112016000612B8 (https=) |
| CA (2) | CA3214545A1 (https=) |
| CL (1) | CL2016000064A1 (https=) |
| DK (1) | DK3019180T3 (https=) |
| ES (1) | ES2743194T3 (https=) |
| IL (2) | IL243366B (https=) |
| MX (2) | MX368912B (https=) |
| MY (2) | MY190309A (https=) |
| NZ (2) | NZ754642A (https=) |
| PH (2) | PH12016500032B1 (https=) |
| RU (1) | RU2671562C2 (https=) |
| SG (2) | SG10201710237PA (https=) |
| WO (1) | WO2015005804A1 (https=) |
| ZA (1) | ZA201600007B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3542813A1 (en) * | 2013-05-31 | 2019-09-25 | The A2 Milk Company Limited | Beta-casein a2 and prevention of inflammation of the bowel |
| JP7137745B2 (ja) * | 2015-05-22 | 2022-09-15 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼインａ２および抗酸化能 |
| WO2017003300A1 (en) * | 2015-06-29 | 2017-01-05 | The A2 Milk Company Limited | A2 beta-casein and viscosity of milk products |
| WO2017171563A1 (en) | 2016-03-30 | 2017-10-05 | The A2 Milk Company Limited | Beta-caseins and cognitive function |
| JP6873234B2 (ja) * | 2016-09-30 | 2021-05-19 | ズィ・エイツー・ミルク・カンパニー・リミテッド | ベータカゼイン類および腸微生物叢 |
| NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
| WO2021003741A1 (zh) * | 2019-07-11 | 2021-01-14 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| CN112205476A (zh) * | 2019-07-11 | 2021-01-12 | 北京三元食品股份有限公司 | β-酪蛋白A2、其组合物在促进双歧杆菌属增殖中的应用 |
| EP4377480A4 (en) * | 2021-07-30 | 2025-09-24 | Active Genomes Expressed Diagnostics Corp | METHODS AND COMPOSITIONS FOR THE TREATMENT OF LIVER CANCER AND LIVER DISEASE |
| AU2024262008A1 (en) * | 2023-04-25 | 2025-11-13 | The A2 Milk Company Limited | Beta-caseins in infant milk formula and use for reducing crying episodes in infants |
| WO2024225919A1 (en) * | 2023-04-25 | 2024-10-31 | The A2 Milk Company Limited | Beta-caseins in infant milk formula and use for reducing regurgitation episodes in infants |
| CN117322467A (zh) * | 2023-10-11 | 2024-01-02 | 东北农业大学 | A2β-酪蛋白在制备功能性食品中的应用 |
| CN117322466A (zh) * | 2023-11-02 | 2024-01-02 | 光明乳业股份有限公司 | 一种新型婴幼儿食用的发酵乳及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2204245C (en) | 1994-11-04 | 2008-07-22 | Robert Bartlett Elliott | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
| US7094949B2 (en) * | 1995-05-16 | 2006-08-22 | A2 Corporation Limited | Breeding and milking cows for milk free of β-casein A1 |
| WO1996036239A1 (en) | 1995-05-16 | 1996-11-21 | Corran Norman Stuart Mclachlan | Food product and process |
| US7029702B2 (en) * | 1998-07-07 | 2006-04-18 | Ritter Natural Sciences Llc | Method for increasing lactose tolerance in mammals exhibiting lactose intolerance |
| AU771754B2 (en) * | 1999-06-29 | 2004-04-01 | New Zealand Milk Institute Limited, The | Prophylactic dietary supplement based on milk |
| AU9037401A (en) | 2000-09-08 | 2002-03-22 | New Zealand Dairy Board | Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders |
| US20060280802A1 (en) * | 2002-10-04 | 2006-12-14 | Campbell Julie H | Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2 |
| DK1663298T3 (da) * | 2003-09-23 | 2019-10-14 | Dsm Ip Assets Bv | Anvendelse af prolinspecifikke endoproteaser til hydrolyse af peptider og proteiner |
| US7618669B2 (en) * | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| CN1899054A (zh) * | 2006-07-17 | 2007-01-24 | 颜贻谦 | 去糖牛奶的制作方法 |
| JP2012522505A (ja) * | 2009-04-03 | 2012-09-27 | ネステク ソシエテ アノニム | ミルク様飲料 |
| AU2010238184B2 (en) * | 2009-04-15 | 2014-09-04 | Glanbia Nutritionals (Ireland) Limited | A reduced lactose milk product and a process for the preparation thereof |
| DE102010009582A1 (de) * | 2010-02-05 | 2011-08-11 | Vitacare GmbH & Co. KG, 60318 | Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz |
| MX389785B (es) * | 2011-07-26 | 2025-03-18 | Nucitec Sa De Cv | Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento. |
| CN103315063A (zh) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | 可预防疾病的婴儿配方奶粉 |
| EP3542813A1 (en) * | 2013-05-31 | 2019-09-25 | The A2 Milk Company Limited | Beta-casein a2 and prevention of inflammation of the bowel |
| US20170086481A1 (en) * | 2014-06-03 | 2017-03-30 | Abbott Laboratories | Nutritional compositions comprising a lipophilic active ingredient |
-
2014
- 2014-07-10 MX MX2016000308A patent/MX368912B/es active IP Right Grant
- 2014-07-10 SG SG10201710237PA patent/SG10201710237PA/en unknown
- 2014-07-10 CN CN201911100359.5A patent/CN110800803A/zh active Pending
- 2014-07-10 ES ES14823628T patent/ES2743194T3/es active Active
- 2014-07-10 SG SG11201510707YA patent/SG11201510707YA/en unknown
- 2014-07-10 BR BR112016000612A patent/BR112016000612B8/pt active IP Right Grant
- 2014-07-10 US US14/904,178 patent/US20160136238A1/en not_active Abandoned
- 2014-07-10 CN CN202210552915.8A patent/CN114832092A/zh active Pending
- 2014-07-10 WO PCT/NZ2014/000141 patent/WO2015005804A1/en not_active Ceased
- 2014-07-10 KR KR1020167003267A patent/KR102367941B1/ko active Active
- 2014-07-10 MY MYPI2019006591A patent/MY190309A/en unknown
- 2014-07-10 MX MX2019012446A patent/MX394585B/es unknown
- 2014-07-10 EP EP19169651.7A patent/EP3542805A1/en active Pending
- 2014-07-10 CN CN201480039570.XA patent/CN105431156A/zh active Pending
- 2014-07-10 MY MYPI2016700051A patent/MY172939A/en unknown
- 2014-07-10 NZ NZ754642A patent/NZ754642A/en unknown
- 2014-07-10 RU RU2015156804A patent/RU2671562C2/ru active
- 2014-07-10 NZ NZ715985A patent/NZ715985A/en unknown
- 2014-07-10 DK DK14823628.4T patent/DK3019180T3/da active
- 2014-07-10 CA CA3214545A patent/CA3214545A1/en active Pending
- 2014-07-10 KR KR1020207019514A patent/KR102291660B1/ko active Active
- 2014-07-10 CA CA2917492A patent/CA2917492C/en active Active
- 2014-07-10 AU AU2014287862A patent/AU2014287862B2/en active Active
- 2014-07-10 JP JP2016525322A patent/JP6436592B2/ja active Active
- 2014-07-10 EP EP14823628.4A patent/EP3019180B1/en not_active Revoked
-
2015
- 2015-12-27 IL IL243366A patent/IL243366B/en active IP Right Grant
-
2016
- 2016-01-04 ZA ZA2016/00007A patent/ZA201600007B/en unknown
- 2016-01-05 PH PH12016500032A patent/PH12016500032B1/en unknown
- 2016-01-12 CL CL2016000064A patent/CL2016000064A1/es unknown
-
2018
- 2018-08-13 IL IL261143A patent/IL261143B/en active IP Right Grant
- 2018-08-17 JP JP2018153472A patent/JP6990154B2/ja active Active
-
2019
- 2019-05-27 AU AU2019203684A patent/AU2019203684B2/en active Active
- 2019-07-03 PH PH12019550112A patent/PH12019550112A1/en unknown
-
2020
- 2020-01-09 US US16/738,792 patent/US20200147173A1/en not_active Abandoned
-
2021
- 2021-12-21 US US17/557,343 patent/US20220175882A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019550112A1 (en) | Beta-casein a2 and reducing or preventing symptoms of lactose intolerance | |
| PH12019550096A1 (en) | Beta-casein a2 and prevention of inflammation of the bowel | |
| MX365614B (es) | Composiciones utiles para tratar trastornos relacionados con kit. | |
| SG10201808055QA (en) | Compositions and methods for reducing major adverse cardiovascular events | |
| TWD161785S (zh) | 皮帶調節具 | |
| MX2015011837A (es) | Co-cristale de pirimetanil y tetracarboximida de ditiina seleccionada. | |
| PH12016500213A1 (en) | Beta-casein a2 and blood glucose levels | |
| MY182845A (en) | Dual-bearing reel | |
| TWD160461S (zh) | 電磁閥之部分 | |
| CL2016001428A1 (es) | Uso de una composicion con ejercicios cognitivos util para la prevencion o el tratamiento de un desarrollo cognitivo retrasado en los niños. | |
| PH12017500763A1 (en) | Nutritional compositions containing a prebiotic and lactoferrin and uses thereof | |
| WO2015027160A3 (en) | Allosteric modulators of the cannibinoid 1 receptor | |
| IN2013CH04898A (https=) | ||
| Al-Daghman | One of the indications of addition in the Quranic context Manifestations of the intention of the appointment and the ratio by adding the pronoun (ha) to the formula (verbs) in the light of appropriate knowledge | |
| PL406123A1 (pl) | Portal internetowy: Twarzą w Twarz | |
| IN2013CH04980A (https=) | ||
| TH159417A (th) | องค์ประกอบที่สามารถเซตตัวได้ที่ประกอบรวมด้วยวอลลาสโตไนต์ และ พิวไมซ์ และวิธีการของการใช้งาน | |
| TWD176685S (zh) | 氣體控制裝置之部分 | |
| TR201010571U (tr) | Sunum ve bakım kiti. | |
| UA88327U (ru) | Способ лечения генерализованного пародонтита при сахарном диабете типа 2 | |
| UA70225U (ru) | Применение композиции, содержащей мирамистин, в качестве лекарственного средства для лечения заболеваний горла | |
| PL405631A1 (pl) | Zasilacz dynamiczny | |
| FR2971123B1 (fr) | Galactofructose pour son effet regulateur du transit intestinal | |
| UA85296U (en) | Dietetic supplement "hawthorn elixir" | |
| UA98759U (uk) | Спосіб друкування нанофотонних елементів активних і розумних паковань |